Dupéré-Richer, Daphné <br/><br/>
Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors.  [electronic resource] 

 -  Leukemia & lymphoma  01 2017 
 - 218-221 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2016.1180684  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Boron Compounds--pharmacology<br/>Bortezomib--pharmacology<br/>Drug Resistance, Neoplasm--genetics<br/>Gene Expression Profiling--methods<br/>Glycine--analogs & derivatives<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Mice, SCID<br/>Prognosis<br/>Proteasome Inhibitors--pharmacology<br/>U937 Cells<br/>Vorinostat<br/>Xenograft Model Antitumor Assays